Project Grant HT94252410726
Award Date 9/30/24
Completion Date 9/29/28
Dollars Obligated $3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tallahassee, FL 32306, USA
Similar Awards
- This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
- This federal Project Grant award, valued at $1,442,321.00 and granted by the Defense Health Agency, supports research at Florida State University (FSU) on "Personalized Dosing of Noninvasive Brain Stimulation Using fNIRS-TMS Technology". The project, funded under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), aims to advance the therapeutic use of non-invasive brain stimulation techniques by developing personalized treatment protocols. Over...
- This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $381,276 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. This award supports research focused on noninvasive vagus nerve stimulation as a therapeutic intervention to improve speech-in-noise perception capabilities in veterans with traumatic brain injury (TBI). The research will...
- This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...
- This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
- The U.S. Defense Health Agency awarded a $2,534,532 Project Grant to Rush University Medical Center to evaluate evidence-based options for initial PTSD treatment non-responders. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a comprehensive range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The award has a performance period of September 1,...
- Federal Project Grant Award Summary The Ohio State University received a $2,976,672 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2029. The award funds research examining the efficacy of short-term intensive Post-Traumatic Stress Disorder (PTSD) treatment on psychological and cognitive impairment symptoms. Research will be conducted at the university's Columbus, Ohio...
- This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
- Federal Grant Award Summary The Defense Health Agency awarded $2.48M through the Military Medical Research and Development program (CFDA 12.420) to the Veterans Medical Research Foundation of San Diego on September 30, 2025, for a Phase 2A clinical trial evaluating the efficacy and safety of PT150 in treating posttraumatic stress disorder (PTSD) in U.S. military veterans. The four-year project, extending through September 29, 2029, will deliver randomized controlled clinical trial services,...